Logo image of BRLT

BRILLIANT EARTH GROUP INC-A (BRLT) Stock Fundamental Analysis

NASDAQ:BRLT - Nasdaq - US1095041000 - Common Stock - Currency: USD

1.5  -0.01 (-0.66%)

Fundamental Rating

3

BRLT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. BRLT has an average financial health and profitability rating. BRLT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BRLT had positive earnings in the past year.
BRLT had a positive operating cash flow in the past year.
BRLT had positive earnings in each of the past 5 years.
Each year in the past 5 years BRLT had a positive operating cash flow.
BRLT Yearly Net Income VS EBIT VS OCF VS FCFBRLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

The Return On Assets of BRLT (-0.02%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -0.43%, BRLT is in line with its industry, outperforming 53.72% of the companies in the same industry.
Industry RankSector Rank
ROA -0.02%
ROE -0.43%
ROIC N/A
ROA(3y)0.4%
ROA(5y)5.45%
ROE(3y)9.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BRLT Yearly ROA, ROE, ROICBRLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

BRLT's Profit Margin has declined in the last couple of years.
BRLT's Operating Margin has declined in the last couple of years.
BRLT has a better Gross Margin (59.98%) than 87.60% of its industry peers.
BRLT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BRLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.98%
OM growth 3Y-57.78%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y6.93%
GM growth 5Y7.4%
BRLT Yearly Profit, Operating, Gross MarginsBRLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

BRLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BRLT has been increased compared to 1 year ago.
The number of shares outstanding for BRLT has been increased compared to 5 years ago.
The debt/assets ratio for BRLT has been reduced compared to a year ago.
BRLT Yearly Shares OutstandingBRLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
BRLT Yearly Total Debt VS Total AssetsBRLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

BRLT has an Altman-Z score of 2.41. This is not the best score and indicates that BRLT is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.41, BRLT is in line with its industry, outperforming 54.55% of the companies in the same industry.
The Debt to FCF ratio of BRLT is 4.87, which is a neutral value as it means it would take BRLT, 4.87 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.87, BRLT is doing good in the industry, outperforming 67.77% of the companies in the same industry.
A Debt/Equity ratio of 2.31 is on the high side and indicates that BRLT has dependencies on debt financing.
With a Debt to Equity ratio value of 2.31, BRLT is not doing good in the industry: 71.07% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.31
Debt/FCF 4.87
Altman-Z 2.41
ROIC/WACCN/A
WACC9.88%
BRLT Yearly LT Debt VS Equity VS FCFBRLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.27 indicates that BRLT has no problem at all paying its short term obligations.
BRLT has a better Current ratio (2.27) than 85.12% of its industry peers.
A Quick Ratio of 1.81 indicates that BRLT should not have too much problems paying its short term obligations.
BRLT has a Quick ratio of 1.81. This is amongst the best in the industry. BRLT outperforms 87.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.27
Quick Ratio 1.81
BRLT Yearly Current Assets VS Current LiabilitesBRLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2

3. Growth

3.1 Past

The earnings per share for BRLT have decreased strongly by -43.75% in the last year.
Looking at the last year, BRLT shows a decrease in Revenue. The Revenue has decreased by -6.14% in the last year.
The Revenue has been growing by 15.96% on average over the past years. This is quite good.
EPS 1Y (TTM)-43.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y3.55%
Revenue growth 5Y15.96%
Sales Q2Q%-3.55%

3.2 Future

BRLT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -28.59% yearly.
The Revenue is expected to grow by 3.12% on average over the next years.
EPS Next Y-54.1%
EPS Next 2Y-28.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.39%
Revenue Next 2Y3.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRLT Yearly Revenue VS EstimatesBRLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
BRLT Yearly EPS VS EstimatesBRLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.67, which indicates a correct valuation of BRLT.
Compared to the rest of the industry, the Price/Earnings ratio of BRLT indicates a somewhat cheap valuation: BRLT is cheaper than 76.03% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, BRLT is valued a bit cheaper.
A Price/Forward Earnings ratio of 24.51 indicates a rather expensive valuation of BRLT.
BRLT's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, BRLT is valued at the same level.
Industry RankSector Rank
PE 16.67
Fwd PE 24.51
BRLT Price Earnings VS Forward Price EarningsBRLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

BRLT's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, BRLT is valued a bit cheaper than 79.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 12.35
BRLT Per share dataBRLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

BRLT's earnings are expected to decrease with -28.59% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-28.59%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BRLT!.
Industry RankSector Rank
Dividend Yield N/A

BRILLIANT EARTH GROUP INC-A

NASDAQ:BRLT (7/11/2025, 8:00:02 PM)

1.5

-0.01 (-0.66%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-07 2025-08-07/amc
Inst Owners29.35%
Inst Owner Change0%
Ins Owners5.97%
Ins Owner Change1.08%
Market Cap148.97M
Analysts73.33
Price Target2.17 (44.67%)
Short Float %0.33%
Short Ratio0.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)426.8%
Min EPS beat(2)100%
Max EPS beat(2)753.6%
EPS beat(4)4
Avg EPS beat(4)605.56%
Min EPS beat(4)100%
Max EPS beat(4)1080.39%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)0.29%
Revenue beat(4)1
Avg Revenue beat(4)-2.01%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)0.29%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-260%
EPS NY rev (1m)3.85%
EPS NY rev (3m)20%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.02%
Valuation
Industry RankSector Rank
PE 16.67
Fwd PE 24.51
P/S 0.36
P/FCF 13.32
P/OCF 9.16
P/B 9.98
P/tB 9.98
EV/EBITDA 12.35
EPS(TTM)0.09
EY6%
EPS(NY)0.06
Fwd EY4.08%
FCF(TTM)0.11
FCFY7.51%
OCF(TTM)0.16
OCFY10.91%
SpS4.22
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.98%
FCFM 2.67%
ROA(3y)0.4%
ROA(5y)5.45%
ROE(3y)9.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.44%
ROCE(5y)21.13%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-57.78%
OM growth 5YN/A
PM growth 3Y-31.26%
PM growth 5YN/A
GM growth 3Y6.93%
GM growth 5Y7.4%
F-Score5
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 2.31
Debt/FCF 4.87
Debt/EBITDA 7.59
Cap/Depr 90.62%
Cap/Sales 1.21%
Interest Coverage N/A
Cash Conversion 357.55%
Profit Quality N/A
Current Ratio 2.27
Quick Ratio 1.81
Altman-Z 2.41
F-Score5
WACC9.88%
ROIC/WACCN/A
Cap/Depr(3y)283.92%
Cap/Depr(5y)318.66%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.52%
Profit Quality(3y)1681.82%
Profit Quality(5y)1572.89%
High Growth Momentum
Growth
EPS 1Y (TTM)-43.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-54.1%
EPS Next 2Y-28.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y3.55%
Revenue growth 5Y15.96%
Sales Q2Q%-3.55%
Revenue Next Year2.39%
Revenue Next 2Y3.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-119.18%
EBIT growth 3Y-56.28%
EBIT growth 5YN/A
EBIT Next Year131.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11086%
FCF growth 3Y-32.07%
FCF growth 5YN/A
OCF growth 1Y31.64%
OCF growth 3Y-27.45%
OCF growth 5Y98.57%